Clinical Trial

Evaluation of Salivary and Serum Levels of TNF-α, IL-17A, and YKL-40 in Individuals With Psoriasis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Background: Periodontitis is a chronic inflammatory disease triggered by microbial infections that lead to the destruction of tissues supporting the teeth. Psoriasis is a chronic skin condition characterized by excessive proliferation and abnormal differentiation of keratinocytes. Due to the presence of similar inflammatory mechanisms, an immunological relationship between psoriasis and periodontal disease has been hypothesized. To explore this relationship, the levels of TNF-α, IL-17A, and YKL-40 in saliva and serum will be examined in both systemically healthy individuals and individuals with psoriasis. Methods: The study will include five distinct groups based on systemic and periodontal conditions: 1. systemically and periodontally healthy individuals (H), 2. systemically healthy individuals with gingivitis (Control Gingivitis, CG), 3. systemically healthy individuals with periodontitis (Control Periodontitis, CP), 4. individuals with psoriasis and gingivitis (Psoriasis Gingivitis, PG), and 5. individuals with psoriasis and periodontitis (Psoriasis Periodontitis, PP). Levels of TNF-α, IL-17A, and YKL-40 will be measured in both saliva and serum samples. Additionally, correlations among these cytokines and between cytokine levels and clinical periodontal parameters-including Plaque Index (PI), Bleeding on Probing (BOP), Probing Pocket Depth (PPD), and Clinical Attachment Level (CAL)-will be analyzed. Conclusion: The study is expected to provide insight into the immunological link between psoriasis and periodontal disease by evaluating TNF-α, IL-17A, and YKL-40 levels at both local (saliva) and systemic (serum) levels.
Trial Details
NCT Number NCT06984237
Lead Sponsor Akdeniz University
Conditions Periodontitis, Psoriasis
Enrollment 100 participants
Start Date 2024-12-02
Primary Completion 2025-04-18 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-05-22